Few hospital-acquired infections are as antibiotic-resistant as Pseudomonas aeruginosa. This opportunistic germ has earned a ...
DermaRite expands recall due to Burkholderia cepacia bacterial infection risk, prompting an FDA warning to destroy their ...
An Instagram post claims that applying a paste of mustard oil, salt, clove, and turmeric can fix tooth decay and toothache ...
Immune checkpoint inhibitors are well known as a form of cancer treatment. Researchers at UZH have now identified a new, ...
The center offers several types of wound treatment, including hyperbaric chamber sessions and free transportation for those ...
Researchers at University of California San Diego School of Medicine have discovered a previously unrecognized mechanism by which Staphylococcus aureus—one of the most common causes of skin and soft ...
News-Medical.Net on MSN
Targeting bacterial communication may offer antibiotic-free wound therapy
Researchers at University of California San Diego School of Medicine have discovered a previously unrecognized mechanism by ...
A Phase 3 study in the U.S. is planned to start in early 2026 to support a submission for FDA approval. MUNICH, Oct. 1, 2025 /CNW/ -- Vertanical today announced publication of results from two Phase 3 ...
Rhapsido is the first FDA-approved BTKi for CSU, targeting patients unresponsive to H1 antihistamines. REMIX trials showed Rhapsido's superiority over placebo in reducing CSU symptoms by Week 12.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback